Metformin Inhibits Chemokine Expression Through the AMPK/NF-κB Signaling Pathway
Authors:
- 1 September 2018
- journal article
- research article
- Published by SAGE Publications in Journal of Interferon & Cytokine Research
- Vol. 38 (9) , 363-369
Abstract
Inflammation is mediated by cytokines and chemokines, which are considered targets of inflammatory diseases. Mounting evidence has demonstrated the anti-inflammatory benefits of metformin. However, the underlying mechanisms are not completely understood. In this study, we aim to elucidate the regulatory effects of metformin on chemokine expression and the possible mechanisms using RAW264.7 cells, a mouse macrophage cell line, as a model. First, we treated the cells with lipopolysaccharide (LPS), and found that the expression of CXCL10 and CXCL11 was markedly induced in a dose- and time-dependent fashion concurrent with the inhibition of AMPK activity. Then, we treated the cells with metformin, and analyzed the expression of CCL2, CXCL10, and CXCL11 by quantitative real-time polymerase chain reaction (PCR). We observed that metformin prevented the stimulating effect of LPS on these chemokines as well as IL-1 and IL-6. Second, the inhibitory effects of metformin on LPS-induced chemokine expression were diminished by Compound C, a chemical inhibitor of AMPK. Finally, we investigated whether the NF-κB signaling pathway is regulated by metformin in this setting. Our results showed that metformin inhibited the phosphorylation of I-κBα and p65 while it activated AMPK. Therefore, the results suggest that metformin inhibits LPS-induced chemokine expression through the AMPK and NF-κB signaling pathways.Keywords
This publication has 32 references indexed in Scilit:
- Tumor-Associated Macrophages: Therapeutic Targets for Skin CancerFrontiers in Oncology, 2018
- Metformin affects the features of a human hepatocellular cell line (HepG2) by regulating macrophage polarization in a co‐culture microenviromentDiabetes/Metabolism Research and Reviews, 2015
- Role of Macrophage Targeting in the Antitumor Activity of TrabectedinCancer Cell, 2013
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- The Many Roles of Chemokines and Chemokine Receptors in InflammationNew England Journal of Medicine, 2006
- Intercellular Adhesion Molecule-1 Deficiency Is Protective against Nephropathy in Type 2 Diabetic db/db MiceJournal of the American Society of Nephrology, 2005
- Macrophages in InflammationCurrent Drug Targets - Inflammation & Allergy, 2005
- The Differential Effects of Metformin on Markers of Endothelial Activation and Inflammation in Subjects with Impaired Glucose Tolerance: A Placebo-Controlled, Randomized Clinical TrialThe Journal of Clinical Endocrinology & Metabolism, 2004
- IFN-γ-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and TraffickingThe Journal of Immunology, 2002
- Chemokines and leukocyte trafficNature, 1998